O-acetyl-(R)-carnitineFinding
O-acetyl-(R)-carnitine decreases interleukin‑6 concentration
lowersModerate evidenceFinding
01 · The sentence it was drawn from
“After three days of the treatment protocol, also the serum levels of TNF- α, IL-6, and ICAM-1, as proinflammatory cytokines, decreased more in the ALC group than in the placebo group (p value = 0.04, 0.02, and 0.03, respectively).”
O-acetyl-(R)-carnitine
Interleukin- 6 concentration
lowers
- Who
- Adults with first-ever acute ischaemic stroke, onset under 24 hours, not candidates for reperfusion therapy, all receiving standard care; change over the 3-day treatment
- Dose studied
- 1000 mg oral ALC three times per day for three consecutive days (nine doses); nasogastric tube if dysphagia
Moderate evidencePMID 35936217 · 2022
02 · The study
- Study
- RCT
- Duration
- 3 days
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Oxidative medicine and cellular longevity04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7MMMZD3C4NAHB7BJC86R8W8